The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Het NBA-seizoen is volop aan de gang. Welke teams en spelers maken indruk? En hoe doet Toumani Camara het? Volg het ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Het Belgische wenskaartenmerk Hello August blaast tien kaarsjes uit. Naar aanleiding van die verjaardag loopt er een ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Bijzondere legervoertuigen op de weg, soldaten bepakt op pad, tanks op een transporttrein en heli’s in de lucht. Inwoners van ...

Bijzondere legervoertuigen op de weg, soldaten bepakt op pad, tanks op een transporttrein en heli’s in de lucht. Inwoners van ...

A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

Gebruikers van EasyPark kregen afgelopen weekend een vervelende mail van de parkeerapp. De servicekosten gaan per 1 mei ...